XML 66 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue Recognition (Tables)
 6 Months Ended
Jun. 29, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following is a summary of our net sales by category (in millions):
Three Months EndedSix Months Ended
June 29, 2024July 1, 2023June 29, 2024July 1, 2023
CSCA(1)
Digestive Health$126.0 $126.1 $248.2 $250.1 
Upper Respiratory118.8 137.3 249.1 291.0 
Nutrition86.1 168.1 176.7 306.6 
Pain and Sleep-Aids81.6 96.7 164.2 200.1 
Oral Care73.2 75.5 137.9 158.8 
Healthy Lifestyle69.1 66.5 140.4 139.9 
Skin Care57.1 61.8 106.7 131.6 
Women's Health16.8 12.8 44.0 25.1 
Vitamins, Minerals, and Supplements ("VMS")5.3 5.0 9.5 9.5 
Other CSCA0.1 1.0 1.6 1.7 
Total CSCA$634.1 $750.8 $1,278.3 $1,514.4 
CSCI
Skin Care$127.7 $123.0 $242.4 $206.4 
Healthy Lifestyle57.5 60.6 122.1 127.0 
Upper Respiratory50.7 64.9 119.8 149.7 
Pain and Sleep-Aids50.3 52.8 101.7 102.7 
VMS39.9 41.5 84.5 89.3 
Women's Health36.9 31.9 68.9 61.0 
Oral Care23.0 21.6 51.7 50.7 
Digestive Health8.5 10.4 18.0 19.2 
Other CSCI(2)
36.8 35.7 60.1 54.4 
Total CSCI431.3 442.4 869.3 860.4 
Total net sales$1,065.5 $1,193.1 $2,147.5 $2,374.8 

(1) We updated our global reporting product categories as a result of legacy sales being moved out of Other CSCA and into respective categories. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.
(2) Consists primarily of the Rare Diseases business and other miscellaneous or otherwise uncategorized product lines and other adjustments, none of which is greater than 10% of the segment net sales.
We generated net sales in the following geographic locations(1) (in millions):
Three Months EndedSix Months Ended
June 29, 2024July 1, 2023June 29, 2024July 1, 2023
U.S.$627.8 $735.8 $1,260.1 $1,486.0 
Europe(2)
408.4 425.7 828.1 832.8 
All other countries(3)
29.3 31.6 59.3 56.0 
Total net sales$1,065.5 $1,193.1 $2,147.5 $2,374.8 
(1) The net sales by geography are derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $11.4 million and $15.7 million for the three and six months ended June 29, 2024, and $11.9 million and $19.1 million for the three and six months ended July 1, 2023.
(3) Includes net sales generated primarily in Australia and Canada.
Schedule of Contract with Customer Balances
The following table provides information about contract assets from contracts with customers (in millions):
Balance Sheet LocationJune 29, 2024December 31, 2023
Short-term contract assetsPrepaid expenses and other current assets$25.6 $28.5